Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
Intervention1: BARYTA MURIATICA 3X: Potenstised homoeopathic medicine Baryta Muriatica in the form of pills
Dose: 2 tablets thrice a day before meal to be prescribed .With the follow up in each 15 da
Sponsors
Dr Bbi Ameena Mysore
Eligibility
Inclusion criteria
Inclusion criteria: 1. Case fulfilling the case definition will be included in the study 2. Patient of all genders will be included 3. patients of age group 25-70 years will be included 4. Cases that include lipid profile abnormality i.e; LDL- Cholesterol above 100mg/dL. 5. ACC/AHA CV RISK CALCULATOR with the range of =7.5% risk
Exclusion criteria
Exclusion criteria: 1.Patients with LDL- Cholesterol above 190mg/dL. 2.Patients with Diabetes Mellitus and are on insulin tretament. 3. Patients with severe cardiac illness, chronic kidney diseases, HTN of grade 2,3. 4. Patients who need emergency medical interventions 5.Acute cases will not be taken during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effect of Baryta Muriatica 3X on reducing Cholesterol level by evaluating its effect on Low density Lipoprotein(LDL-C)Timepoint: The follow ups will be taken after 15 days and will be assessing the effect of Baryta Muriatica 3X | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the effect of Baryta Muriatica 3X on newly diagnosed cases of Hyperlipidemia with Primary Hypertension under the age criteria for 25-70 yearsTimepoint: The follow ups will be of 15 days & will be assess the effect of Baryta Muriatica 3X | — |
Countries
India
Contacts
Public ContactDr Bibi Ameena Mysore
Bharati Vidyapeeth (Deemed To Be University) Homoeopathic Medical College And Pune
Outcome results
None listed